Profiles of discontinuation and switching of thiazide diuretics: A cohort study among 9398 Chinese hypertensive patients

Hypertension Research

Volumn 34, Issue 7, 2011, Pages 888-893

  Wong, Martin C S ^a   Su, Xuefen ^a   Jiang, Johnny Y ^b   Tang, Jin Ling ^a   Griffiths, Sian M ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

associated factors; Chinese; discontinuation; switching; thiazide diuretic

Indexed keywords

THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHINESE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SEX FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 79960025405     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.43     Document Type: Article

References (32)

1. National Collaborating Centre for Chronic Conditions. Hypertension: Management in Adults in Primary Care: Pharmacological Update. Royal College of Physicians: London, 2006.
2. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte OP, Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007; 28: 2375-2414. (Pubitemid 47542237)
3. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992. (Pubitemid 38296854)
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC-7 report. JAMA 2003; 289: 2560-2572.
5. ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
6. Tu K, Campbell NRC, Duong-Hua M, McAlister FA. Hypertension management in the elderly has improved: Ontario prescribing trends, 1994 to 2002. Hypertension 2005; 45: 1113-1118. (Pubitemid 40770314)
7. Walley T, Duggan AK, Haycox AR, Niziol CJ. Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK. J R Soc Med 2003; 96: 525-531. (Pubitemid 37510420)
8. Ma J, Lee K-V, Stafford RS. Changes in antihypertensive prescribing during US Outpatient visits for uncomplicated hypertension between 1993 and 2004. Hypertension 2006; 48: 846-852. (Pubitemid 44610996)
9. Wong MC, Jiang JY, Lam AT, Fung H, Griffiths S, Mercer SW. Patterns of antihyperten-sive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. J Hum Hypertens 2008; 22: 714-716.
10. Wong MCS. Short-and long-term discontinuation patterns of commonly prescribed antihypertensive drugs among a Chinese population: cohort study. J Hum Hypertens 2008; 22: 435-437. (Pubitemid 351712391)
11. Wong MCS, Jiang JY, Gibbs T, Griffiths S. Factor associated with antihypertensive drug discontinuation among Chinese patients: a cohort study. Am J Hypertens 2009; 22: 802-810.
12. Wong MCS, Jiang JY, Griffiths S. Switching of antihypertensive drugs among 93,286 Chinese patients: a cohort study. J Hum Hypertens 2010; 24: 669-677.
13. Wong MCS, Jiang JY, Griffiths S. Factor associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients. Am J Hypertens 2009; 22: 904-910.
14. Wong MCS, Jiang JY, Lam AT, Fung H, Griffiths S, Mercer SW. Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Services Research 2008; 8: 138
15. HA and clinical research\support, output and direction. Available at http://www.ha.org.hk/ho/research-ethics/msdc-p181.pdf. Accessed on 06 Oct, 2009.
16. Population by census, 2006. Hong Kong Special Administrative Region, China. http://www.bycensus2006.gov.hk/en/index.htm. Accessed September 14, 2009.
17. Burke TA, Sturkenboom MC, Lu S, Wenworth CE, Lin Y, Rhoads GG. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006; 24: 1193-1200. (Pubitemid 43772328)
18. Mazzaglia G, Mantovani LG, Sturkenboom MCJM, Filippi A, Trifirò G, Cricelli C, Brignoli O, Caputi AP. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23: 2093-2100. (Pubitemid 41830406)
19. Katz MH (ed.) Multivariable Analysis: A Practical Guide for Clinicians, 2nd edn. Cambridge University Press: Cambridge, 2006, pp 69.
20. Jiang JY, Wong MCS, Ali MK, Griffiths SM, Mercer SW. Association of antihypertensive monotherapy with serum sodium and potassium levels in Chinese patients. Am J Hypertens 2009; 22: 243-249.
21. Wong MCS, Jiang JY, Ali MK, Fung H, Griffiths S, Mercer SW. Antihypertensive drug class and dyslipidemia: risk association among Chinese patients with uncomplicated hypertension. J Hum Hypertens 2008; 22: 648-651.
22. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27: 481-490. (Pubitemid 26084617)
23. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncom-pliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000; 20: 941-949. (Pubitemid 30659791)
24. Carter BL. Adherence, quality of life, cost effectiveness, and the role of the pharmacist. In: Lip GYH, Hall JE (eds). Comprehensive Hypertension. Mosby Elsevier: Philadelphia, 2007, pp 1119-1127.
25. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ 1999; 160: 31-37. (Pubitemid 29054224)
26. Degli Esposti L, Degli Esposti E, Valpiani G, Di Martino M, Saragoni S, Buda S, Baio G, Capone A, Sturani A. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther 2002; 24: 1347-1357. (Pubitemid 35026158)
27. Vaur L, Vaisse B, Genes N, Elkik F, Legrand C, Poggi L. Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large-scale trial. Am J Hypertens 1999; 12: 374-380. (Pubitemid 29200055)
28. Flack JM, Novikov SV, Ferrario CM. Benefits of adherence to antihypertensive drug therapy. Eur Heart J 1996; 17SA: 16-20. (Pubitemid 26129714)
29. Degli Esposti E, Sturani A, Di Martino M, Falasca P, Novi MV, Baio G, Buda S, Volpe M. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 2002; 16: 439-444. (Pubitemid 34685595)
30. Mickley H. Incidence and treatment of sexual dysfunction in heart disease. Ugeskrift for Laeger 2002; 164: 4760-4764. (Pubitemid 35230556)
31. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997; 95: 1085-1090. (Pubitemid 27091557)
32. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 2004; 164: 722-732. (Pubitemid 38478694)